Back to Search
Start Over
Rituximab in a risk‐adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte‐predominant Hodgkin lymphoma.
- Source :
-
British Journal of Haematology . Sep2018, Vol. 182 Issue 5, p715-718. 4p. 1 Diagram, 1 Chart. - Publication Year :
- 2018
- Subjects :
- *RITUXIMAB
*HODGKIN'S disease treatment
*NODULAR disease
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 182
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 131393465
- Full Text :
- https://doi.org/10.1111/bjh.14856